Riskpilot← Back to searchSign inGet full accessROSENBORGKLINIKKEN FYSIOTERAPI AS
ASActiveOrg 913367022Lerkendal Stadion Odd Iversens Veg 2, 7031 TrondheimRental and operating of own or leased real estate · NACE 6820Est. 20140 employees
Revenue 2024
NOK 4M
+19% vs 2023
EBITDA margin
9.7%
+161% vs 2023
Equity ratio
57.6%
Financial strength
Net profit 2024
NOK 329K
+382% vs 2023
| Revenue | NOK 4M | +19% |
| EBITDA | NOK 384K | +161% |
| Net profit | NOK 329K | +382% |
| Total assets | NOK 1,4M | +141% |
| Equity | NOK 794K | +71% |
| Employees | 0 | — |
Legal name
ROSENBORGKLINIKKEN FYSIOTERAPI AS
Org number
913367022
Legal form
Aksjeselskap
NACE code
6820 · Rental and operating of own or leased real estate
Founded
25. mars 2014
Share capital
NOK 30 600
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Drive fremleie av lokaler knyttet til fysioterapivirksomhet og annen virksomhet som står i naturlig sammenheng med dette.
Address
Lerkendal Stadion Odd Iversens Veg 2, 7031 Trondheim
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 532 | 2 494 | 3 309 | 3 349 | 3 974 |
| Staff expenses | −0 | −0 | −684 | −847 | −1 007 |
| EBITDA | 379 | 58 | −238 | 147 | 384 |
| Depreciation & amort. | −60 | −60 | −61 | −69 | −31 |
| EBIT | 318 | −2 | −299 | 78 | 353 |
| Net financials | 0 | 0 | 0 | −10 | 0 |
| Profit before tax | 318 | −2 | −299 | 68 | 353 |
| Tax | 64 | 4 | −0 | −0 | 24 |
| Net profit | 254 | −7 | −299 | 68 | 329 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 946 | 936 | 1 011 | 572 | 1 378 |
| Equity | 702 | 696 | 397 | 465 | 794 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 244 | 240 | 614 | 106 | 584 |
| Total debt | 244 | 240 | 614 | 106 | 584 |
EBITDA margin
9.7%
This company
15.8%
Market median
-39% vs market
20202024
Equity ratio
57.6%
This company
38.2%
Market median
+51% vs market
20202024
Return on equity
41.4%
This company
18.4%
Market median
+125% vs market
20202024
Net profit margin
8.3%
This company
8.1%
Market median
+2% vs market
20202024
Asset turnover
2.88×
This company
1.12×
Market median
+157% vs market
20202024
Debt / equity
0.74×
This company
0.62×
Market median
+19% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2023 | |
| Board of Directors | 2023 | |
| Former (1) | ||
| Board of Directors | 2020 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 16.34% | 16.34% | 2024 | |
| Individual | 16.34% | 16.34% | 2024 | |
| Individual | 16.34% | 16.34% | 2024 | |
| Individual | 16.34% | 16.34% | 2024 | |
| Individual | 16.34% | 16.34% | 2024 | |
| Company | 16.34% | 16.34% | 2024 | |
| Company | 12.42% | 12.42% | 2022 | |
| Company | 1.96% | 1.96% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ROSENBORGKLINIKKEN FYSIOTERAPI AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sigbjørn Hammer | Board of Directors | 0 companies |
| Håvard Østerås | Board of Directors | 0 companies |
| Haakon Schwabe | Board of Directors | 0 companies |